Therefore, N19 likely acts as an HSP90 inhibitor and may overcome EGFR-TKI resistance and destroy EGFR-mutated NSCLC cells via degradation of EGFR and cMET proteins by ubiquitin proteasomes. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.